Galibier Capital Management Ltd. Medtronic PLC Transaction History

Galibier Capital Management Ltd.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 08, 2022	BUY	$99.53 - $127.75 $199,060 - $255,500	2,000 Added 23.07%	10,670 $1.1 Million
Q3 2021 Oct 20, 2021	SELL	$122.75 - $135.17 $306,875 - $337,924	-2,500 Reduced 22.38%	8,670 $1.09 Million
Q2 2020 Aug 05, 2020	BUY	$84.11 - $103.33 $84,110 - $103,330	1,000 Added 9.83%	11,170 $1.02 Million
Q1 2020 Apr 21, 2020	BUY	$72.92 - $121.3 $261,053 - $434,254	3,580 Added 54.32%	10,170 $917,000
Q4 2019 Jan 14, 2020	SELL	$104.49 - $114.54 $476,474 - $522,302	-4,560 Reduced 40.9%	6,590 $748,000
Q3 2019 Nov 08, 2019	SELL	$98.02 - $111.18 $10.1 Million - $11.5 Million	-103,154 Reduced 90.25%	11,150 $1.21 Million
Q2 2019 Aug 02, 2019	BUY	$84.15 - $99.38 $9.62 Million - $11.4 Million	114,304 New	114,304 $11.1 Million

2,285

1.02B

8.05M

7.19M

Ticker MDT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,329,149,952
Market Cap $115B
Description
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...

Get notified when there are updates to the investment portfolio of Galibier Capital Management Ltd., based on Form 13F filings with the SEC.

Stay updated on Galibier Capital Management Ltd. with notifications on news.